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A report of the meeting ‘From Proteomics to Lipidomics -
Basics, Advances and Applications’, Bonn, Germany, 30 June-
1 July 2006.
The global analysis of biomolecules such as proteins, lipids
and carbohydrates within a tissue, cell or organelle under
specific physiological situations is a major challenge of the
post-genomic era. Experts from the fields of proteomics,
lipidomics and metabolomics discussed this challenge at a
recent meeting on these topics in Bonn.
Our ability to determine large numbers of proteins from a
biological sample has dramatically increased through the
development of soft-ionization techniques and the growing
availability of state-of-the-art mass spectrometers, even in
non-specialist laboratories. One of the pioneers in applying
mass spectrometry to biomolecules, Franz Hillenkamp
(University of Münster, Germany), gave an excellent intro-
duction to the basic mechanisms of matrix-assisted laser
desorption/ionization (MALDI). He discussed the use of
MALDI-MS for the imaging of biological tissue and
proposed the use of infrared-laser rather than the more
commonly used UV-lasers for this aim. Using this different
setting, the critical matrix preparation step can be avoided
and analytes can be directly ionized, thereby preventing
artificial results. Boris Macek (Max Planck Institute of
Biochemistry, Munich, Germany) gave an introduction to
electrospray-ionization (ESI) mass spectrometry and
described the use of high-resolution Fourier-transform mass
spectrometers to perform top-down mass spectrometry of
intact proteins and high-throughput analysis of whole
proteomes. In both instances, internal calibration on an ion
with a known mass (known as the lock mass) resulted in a
resolution power of more than 60.000 and mass deviations
of less than 2 ppm. This new degree of accuracy will boost
the level of confidence with which proteins can be identified
and is therefore crucial for future proteomic research.
Alexandre Shvartsburg (Pacific NW National Laboratory,
Richland, USA) showed that the analysis of ions using field-
asymmetric waveform ion-mobility spectrometry (FAIMS)
in conjunction with mass spectrometry could be used to
perform ultrahigh-throughput studies on conformational
isomers of proteins even within complex mixtures.
Although many proteins in complex samples can currently
be identified using these approaches, the description of a full
proteome of a whole organism such as yeast still provides a
great challenge. This is, as Rudi Aebersold (Institute of
Molecular Systems Biology, Zürich, Switzerland) pointed
out, due to considerable under-sampling by the mass
spectrometers now in use and the enormous complexity of
the samples studied. A possible solution to the complexity
problem and the resulting under-sampling may be offered by
the technique presented by Joel Vandekerckhove (University
of Gent, Belgium). The method, which he termed combined
fractional diagonal chromatography (COFRADIC), relies on
the analysis of a subset of specific peptides from a given
protein such as the amino-terminal peptide or cysteine-
containing peptides. The information gathered from this
approach is sufficient to identify proteins from the analysis
of a single peptide and thus considerably reduces the degree
of complexity within a sample.
To get quantitative information on the amount of a protein
and its interactions and relationships with other proteins, an
enormous amount of information not only has to be
recorded but also has to be analyzed. Peer Bork (European
Molecular Biology Laboratory, Heidelberg, Germany)
introduced the protein network analysis tool STRING
developed in his lab (available from the STRING website
[http://string.embl.de/]), which integrates data from more
than 30 million predicted and experimentally derived
protein interactions and offers a variety of interaction and
network-analysis options. For the display of network data,the Bork lab has created MEDUSA, a graph viewer
[http://coot.embl.de/medusa/]. A further step towards a full
description of a simple biological system was provided by
Uwe Sauer (Institute of Molecular Systems Biology, Zürich,
Switzerland), who described his work on the metabolic flux
of 13C among different metabolites within a bacterial cell. His
work revealed that metabolic networks within bacteria are
surprisingly robust and rigid, with the relative flux of carbon
not being affected by random genetic perturbations. This
stability sheds new light on our view of how metabolic
pathways evolve.
Despite the limitations in current technologies, mass
spectrometry is frequently used to improve the diagnosis of
human diseases and to aid drug discovery. One big hope is
that high-throughput comparative proteomics will be able to
detect biomarkers that have a diagnostic value. However, as
Denis Hochstrasser (Geneva University Hospital, Switzer-
land) pointed out, any marker that is to be useful in clinical
practice has to have low false-positive and false-negative
rates - a criterion that has so far not been met by any marker
detected purely by mass spectrometric methods. The use of
mass spectrometry in drug discovery is showing more
promise. For example, Bernhard Küster (Cellzome AG,
Heidelberg, Germany) who reported the use of immobilized
small-molecule kinase inhibitors to purify their target
kinases from cellular extracts and the subsequent
identification of the kinases by liquid chromatography-
tandem mass spectrometry (LC-MS/MS) methods. These
experiments revealed new specificities for the kinase
inhibitors for enzymes they were not initially targeted to.
These surprising results can be used to improve inhibitor
specificities and to predict possible new applications for
these small molecules.
The important roles of lipids in cell, tissue and organ
physiology have been demonstrated by a large number of
genetic studies. The cellular lipidome comprises more than
1,000 different lipids, and they are generally accepted to be
key factors in the regulation of cell function and to be
important players in diseases such as cancer, diabetes and
neurodegenerative diseases. New techniques such as
LC-MS/MS and the coupling of triple quadrupole and hybrid
quadrupole ion-trap instruments to high-resolution LC are
being applied to lipidome analysis. Jasna Peter-Katalinic
(Institute of Medical Physics and Biophysics, Münster,
Germany) discussed methods that allow the efficient
ionization of glycolipids using either ESI and/or MALDI.
She showed that ESI, in combination with accessory tools
such as capillary electrophoresis, could be very useful for the
analysis of complex mixtures from body fluids, tissue culture
and human tissues. Used with automated sample delivery
such a combination would then allow high-throughput screen-
ing. Andrei Shevchenko (Max Planck Institute, Dresden,
Germany) provided an interesting insight into the high mass
resolution LTQ-Orbitrap mass spectrometer (Thermo Electron
Corporation). LTQ-Orbitrap machines are very useful for
qualitative applications such as shotgun lipidomics; for
example, under pathophysiological conditions altered lipid-
ome profiles can be analyzed very rapidly, providing quali-
tative and quantitative data. Alfred Merrill (Smithgall
Institute, Georgia, USA) addressed the problem of visualiza-
tion the enormous amounts of data being generated. This
requires models that facilitate pattern recognition, considers
changes with time, and allows a comparison among groups
(see the lipidmap and sphingomap websites [http://www.
lipidmaps.org] [http://www.sphingomap.org]). Describing
the application of these tools to sphingolipid metabolism,
Merrill reported that when serine palmitoyltransferase was
stably overexpressed (this is the first enzyme of the
sphingolipid biosynthesis pathway that is thought to
induce ceramide biosynthesis), galactosylceramide instead
of glycosylceramide was formed.
It will be a challenge to understand how cells use their
thousands of different lipid molecules to regulate their
structure and function. As an approach to this goal, Gerrit
van Meer (Bijvoet Center and Institute of Biomembranes,
Utrecht, The Netherlands) emphasized the concept of
cellular lipidomics. This field embraces the enzymes of lipid
metabolism, and their transport, specificity, localization and
regulation. He described an example of how Golgi ceramide
pools might regulate the pH of intracellular compartments.
He and his colleagues have studied the transmembrane
flippase that is responsible for flipping glycosylceramide
continuously to the exoplasmic surface of a membrane.
Glycosylceramide binds to V-ATPase in the trans Golgi
network, which can be stimulated by some glycolipids. In
mutants unable to synthesize glycosphingolipids the pH in
the compartments was one unit higher than in controls.
Mechanisms of protein-mediated translocation of lipids
across cellular membranes, their intracellular transport to
distinct organelles, and protein-mediated lipid transport
were also the focus of the talk by Thomas Pomorski
(Humboldt University, Berlin, Germany). His group studies
protein mixtures enriched in flippase members of the family
of plasma membrane P4-ATPases (Dnf1p and Dnf2p) in
yeast, which are most probably involved in inward ATP-
driven lipid transport. Their studies have established yeast
as a promising model for the analysis of protein-mediated
translocation of lipids. Nevertheless, better methods are
needed to study this process at the subcellular level.
Pomorski uses photoactivatable and fluorescent lipids that
mimic natural lipids as promising tools to study lipid
translocation.
In vivo studies give insight into the role of lipids in
development, differentiation, signaling and disease. Julie
Saba (Children’s Hospital and Research Center, Oakland,
USA) reported her analysis of the role of sphingosine 1-
phosphate (S1P) and the enzyme responsible for its
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in colon cancer. S1P is a sphingolipid metabolite that
regulates cell proliferation, migration and apoptosis through
specific signaling pathways. Using Drosophila as a model
system, Saba showed that complex developmental patholo-
gies can be directly linked to a disruption of sphingolipid
catabolism. Extending her studies to mice, she showed that
SPL is downregulated in early adenomatous lesions of the
Min mouse model for intestinal tumorigenesis. In addition,
SPL expression was significantly downregulated in human
colon cancer tissues, the first example of altered SPL
expression in a human tumor. On the basis of these findings
she suggested that endogenous SPL might play a physio-
logical role in stress-induced apoptosis. The role of lipids,
especially sphingolipids, in disease was further emphasized
by Michaela Dragusin (Kekulé Institute of Organic
Chemistry and Biochemistry, Bonn, Germany). She showed
that the function of intestinal smooth muscle cells is
particularly affected by the activity of both ceramide
1-phosphate (C1P) and S1P. Thus, sustained raised concen-
trations of the two bioactive sphingolipids in this tissue after
intestinal surgery could, at least in part, explain post-
operative intestinal dysmotility.
The emerging field of systems biology tries to integrate all
information that can be gathered for a particular biological
system in order to derive predictive models for its reaction to
external or internal disturbances. Meetings like this
symposium contribute to the progress of systems biology by
bringing together researchers with expertise in the multiple
‘-omics’ technologies. The formation of such research
networks will ultimately help us to better understand the
network of life.
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